Mark L Robbins

Prof. Dr. Mark L Robbins

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2014 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
AWAmy D Waterman
Amy D Waterman
MRMark L Robbins
Mark L Robbins
Andrea PaivaAndrea Paiva
Andrea Paiva
JPJohn Devin Peipert
John Devin Peipert
CKCrystal S Kynard-Amerson
Crystal S Kynard-Amerson
LBLeslie A Brick
Leslie A Brick
Because of the deceased donor organ shortage, more kidney patients are considering whether to receive kidneys from family and friends, a process called living donor kidney transplantation (LDKT). Although Blacks and Hispanics are 3.4 and 1.5 times more likely, respectively, to develop end stage renal disease (ESRD) than Whites, they are less likely to receive LDKTs. To address this disparity, a new randomized controlled trial (RCT) will assess whether Black, Hispanic, and White transplant patients’ knowledge, readiness to pursue LDKT, and receipt of LDKTs can be increased when they participate in the Your Path to Transplant (YPT) computer-tailored intervention. Nine hundred Black, Hispanic, and White ESRD patients presenting for transplant evaluation at University of California, Los Angeles Kidney and Pancreas Transplant Program (UCLA-KPTP) will be randomly assigned to one of two education conditions, YPT or Usual Care Control Education (UC). As they undergo transplant evaluation, patients in the YPT condition will receive individually-tailored telephonic coaching sessions, feedback reports, video and print transplant education resources, and assistance with reducing any known socioeconomic barriers to LDKT. Patients receiving UC will only receive transplant education provided by UCLA-KPTP. Changes in transplant knowledge, readiness, pros and cons, and self-efficacy to pursue LDKT will be assessed prior to presenting at the transplant center (baseline), during transplant evaluation, and 4- and 8-months post-baseline, while completion of transplant evaluation and receipt of LDKTs will be assessed at 18-months post-baseline. The RCT will determine, compared to UC, whether Black, Hispanic, and White patients receiving YPT increase in their readiness to pursue LDKT and transplant knowledge, and become more likely to complete transplant medical evaluation and pursue LDKT. It will also examine how known patient, family, and healthcare system barriers to LDKT act alone and in combination with YPT to affect patients’ transplant decision-making and behavior. Statistical analyses will be performed under an intent-to-treat approach. At the conclusion of the study, we will have assessed the effectiveness of an innovative and cost-effective YPT intervention that could be utilized to tailor LDKT discussion and education based on the needs of individual patients of different races in many healthcare settings. ClinicalTrials.gov, number NCT02181114 .

15 September 2020 in American Journal of Transplantation
Verified
Journal Article
Open access
AWAmy D. Waterman
Amy D. Waterman
JPJohn Devin Peipert
John Devin Peipert
YCYujie Cui
Yujie Cui
JBJennifer L. Beaumont
Jennifer L. Beaumont
APAndrea Paiva
Andrea Paiva
MRMark L Robbins
Mark L Robbins
Individually tailoring education over time may help more patients, especially racial/ethnic minorities, get waitlisted and pursue deceased and living donor kidney transplant (DDKT and LDKT, respectively). We enrolled 802 patients pursuing transplant evaluation at the University of California, Los Angeles Transplant Program into a randomized education trial. We compared the effectiveness of Your Path to Transplant (YPT), an individually tailored coaching and education program delivered at 4 time points, with standard of care (SOC) education on improving readiness to pursue DDKT and LDKT, transplant knowledge, taking 15 small transplant-related actions, and pursuing transplant (waitlisting or LDKT rates) over 8 months. Survey outcomes were collected prior to evaluation and at 4 and 8 months. Time to waitlisting or LDKT was assessed with at least 18 months of follow-up. At 8 months, compared to SOC, the YPT group demonstrated increased LDKT readiness (47% vs 33%, P = .003) and transplant knowledge (effect size [ES] = 0.41, P < .001). Transplant pursuit was higher in the YPT group (hazard ratio: 1.44, 95% confidence interval: 1.15-1.79, P = .002). A focused, coordinated education effort can improve transplant-seeking behaviors and waitlisting rates. ClinicalTrials.gov registration: NCT02181114.

9 May 2016 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
LSLisa G. Suter
Lisa G. Suter
CBClaire E. Barber
Claire E. Barber
JHJeph Herrin
Jeph Herrin
ALAmye Leong
Amye Leong
ELElena Losina
Elena Losina
JYJinoos Yazdany
Jinoos Yazdany
Objective: To highlight the opportunities and challenges of developing and implementing performance outcome measures in rheumatology for accountability purposes.Methods: We constructed a hypothetical performance outcome measure to demonstrate the benefits and challenges of designing quality measures that assess patient outcomes. We defined the data source, measure cohort, reporting period, period at risk, measure outcome, outcome attribution, risk adjustment, reliability and validity, and reporting approach. We discussed outcome measure challenges specific to rheumatology and to fields where patients have predominantly chronic, complex, ambulatory care–sensitive conditions.Results: Our hypothetical outcome measure was a measure of rheumatoid arthritis disease activity intended for evaluating Accountable Care Organization performance. We summarized the components, benefits, challenges, and tradeoffs between feasibility and usability. We highlighted how different measure applications, such as for rapid cycle quality improvement efforts versus pay for performance programs, require different approaches to measure development and testing. We provided a summary table of key take‐home points for clinicians and policymakers.Conclusion: Performance outcome measures are coming to rheumatology, and the most effective and meaningful measures can only be created through the close collaboration of patients, providers, measure developers, and policymakers. This study provides an overview of key issues and is intended to stimulate a productive dialogue between patients, practitioners, insurers, and government agencies regarding optimal performance outcome measure development.

1 August 1998 in Academic Emergency Medicine
Verified
Journal Article
Open access
PDF file
JHJerris R Hedges
Jerris R Hedges
NMNewell Clay Mann
Newell Clay Mann
HMHendrika Meischke
Hendrika Meischke
MRMark L Robbins
Mark L Robbins
RGRobert Goldberg
Robert Goldberg
JZJane Zapka
Jane Zapka
Objective: To determine the consistency of responses to a standardized 2‐part “key” question (Key‐Q) about acute symptom onset in patients presenting with chest pain when measured using alternative questions (Qs) about symptom perception and decisions to seek treatment. Methods: A structured patient interview was performed at 3 university teaching hospitals and 1 community hospital. Convenience samples of adult patients presenting to these EDs with chest pain were asked specific questions related to their symptoms and recognition of illness. Information obtained included the 2‐part Key‐Q: “What are the symptoms that brought you here today?” and “When did those symptoms start?” The alternative Qs (in order of use) were as follows: Ql =“When did your very first symptom or sensation begin?”; Q2 =“When did your symptoms lead you to think something was wrong or that you were ill?”; Q3 =“When did your symptoms become serious enough for you to seek medical care?”; and Q4 =“When did you actually call 9‐1‐1/emergency medical services (EMS) or go to the hospital?” The documented ED arrival time, demographic variables, and whether the patient arrived by ambulance were obtained from the medical record. Patients also were queried regarding potential barriers to seeking medical care and their cardiac risk factors. Results: Of the 135 patients surveyed, 9 were unsure of the date and time of symptom onset. For the 126 patients with analyzable data, the mean (±SD) patient age was 62 ± 16 years, and 59% were male. The general sequence of events reported from acute symptom onset until hospital care was Q1/ Key‐Q ← Q2 ← Q3 ← Q4 ← ED arrival. The median differences and interquartile ranges (IQRs) in minutes between Q times and the Key‐Q response were: Q1 = 0 (0‐0); Q2 = 30 (0–210); Q3 = 140 (30–720); Q4 = 265 (90‐1,215); and ED arrival = 340 (120‐1,230). The interval from the Key‐Q response until calling 9‐1‐1/EMS or going to the hospital was shorter for those who used an ambulance and for those who did not consult a physician first. The interval from the Key‐Q response until considering symptoms to be serious was shorter for those with a family history of heart disease, but longer for non‐white patients. Conclusion: The Key‐Q elicited a response recalled near the time of first symptoms and generally before the patient had concluded something was “wrong or that he or she was ill.” Measurement of the out‐of‐hospital delay in chest pain patients using the Key‐Q appears promising.

1 May 2012 in American Journal of Health Promotion
Verified
Journal Article
Closed access
CBCerissa L. Blaney
Cerissa L. Blaney
MRMark L Robbins
Mark L Robbins
APAndrea L. Paiva
Andrea L. Paiva
CRColleen A Redding
Colleen A Redding
JRJoseph S. Rossi
Joseph S. Rossi
KOKarin Oatley
Karin Oatley
Purpose.: African-Americans have high rates of physical inactivity-related morbidity and mortality, thus effective interventions to increase exercise are necessary. Tailored interventions show promise, but measures need validation in this population. This study validated transtheoretical model measures for exercise in an African-American sample. Design.: Cross-sectional measure development. Setting.: Telephone survey of individuals in North Carolina. Subjects.: 521 African-American adults. Measures.: Stages of change, decisional balance (pros and cons), self-efficacy and processes of change (POC) for regular exercise. Analysis.: Confirmatory factor analyses tested measurement models. Multivariate analyses examined relationships between each construct and stages of change. Results.: For decisional balance, the two-factor uncorrelated model was the most parsimonious good-fitting model (χ 235 = 158.76; comparative fit index [CFI], .92; average absolute standardized residual [AASR], .04), and alphas were good (pros α = .85 and cons α = .74). The one-factor model for self-efficacy (α = .80) revealed an excellent fit (χ 29 = 45.51; CFI, .96; AASR, .03). For the POC subscales with good alphas (α = .62–.91), a 10-factor fully correlated model fit best (χ 2 [360] = 786.75; CFI, .91; AASR, .04). Multivariate analyses by stage of change replicated expected patterns for the pros, self-efficacy, and POC measures with medium-sized effects (η 2 = .05–.13). Results by stage of change did not replicate for the cons scale. Conclusions.: The structures of these measures replicated with good internal and external validity, except for the cons scale, which requires additional development. Results support the use of these measures in tailored interventions to increase exercise among African-Americans.

6 May 2014 in Health Promotion Practice
Verified
Journal Article
Closed access
MRMark L Robbins
Mark L Robbins
APAndrea L. Paiva
Andrea L. Paiva
NANicole R. Amoyal
Nicole R. Amoyal
LBLeslie Brick
Leslie Brick
DKDebra A. Kessler
Debra A. Kessler
BSBeth H. Shaz
Beth H. Shaz
Introduction. A pilot test of a computer-tailored intervention designed to promote blood donation among Blacks was conducted. Method. Intervention content, based on the transtheoretical model, offered participants individually and culturally tailored information on blood donation with emphasis on need specific to race (e.g., sickle-cell disease). Black adults (N = 150) with a diversity of blood donation experience were recruited from a blood center and a survey recruitment website. Posttest assessment included a 14-item evaluation and transtheoretical model questions. Results. Participants rated the program positively (81.3% to 98.7% of participants agreeing or strongly agreeing with evaluation items). For example, 98.7% of respondents reported that the program gave sound advice and that personal feedback was easily understood, and 87.3% felt the program was designed for people like themselves. Ninety-five percent of participants reported that they would recommend the program to others. There were no significant differences in ratings based on demographics. Qualitative responses support program acceptability. Furthermore, pre- and postprogram assessments indicated an increase in intention to donate, t(149) = 3.56, p = .001, d = .29. Discussion. With acceptability and feasibility confirmed, the next steps are to test efficacy and cost-effectiveness for use to increase blood donation, particularly in priority populations.